Citenazone

InformationTriazavirin Triazavirin (TZV, Riamilovir) is a novel antiviral drug, a nucleoside analogue of nucleic acid that inhibits the synthesis of viral RNA and DNA and replication of genomic fragments. Triazavirin is active against influenza and

VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD) , with IC 50 of 0.34 μM for full-length human AR. VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with

VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD) , with IC 50 of 0.34 μM for full-length human AR. VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with

VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD) , with IC 50 of 0.34 μM for full-length human AR. VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with

Warm Zone ARK SRO Version - Green

HIV-1 inhibitor: inhibition of HIV replication:.

VEGFR2 kinase inhibitors.

inhibiting HIV-1 replication.

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt:0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate